HomeTagsExon 44 Skipping Therapies

Exon 44 Skipping Therapies

Mutations and Deletions Amenable to Exon 44 Skipping Therapies for Duchenne Muscular Dystrophy

Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy

Entrada Therapeutics Announces Phase 1/2 Results for ENTR-601-44 in Duchenne Muscular Dystrophy

Del-Zota Phase 3 SAFARI44 Clinical Trial for Duchenne Muscular Dystrophy: Study Design, Data, and Clinical Significance

Data Monitoring Committee Recommended Initiating an Increased Dose for Group 2 in Entrada’ Exon 44 Skipping Study

Entrada Therapeutics Announced It will Report Data from its Exon Skipping Studies in 2026

Del-Zota Clinical Trial Begins in the US in Participants with DMD Mutations Amenable to Exon 44 Skipping

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota (Exon 44 Skipping)

Avidity Biosciences to be Acquired by Novartis

12 3 Page 1 of 3

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

Care Guidelines

Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage

Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy

RGX-202 Duchenne Gene Therapy Shows NSAA Improvement and Microdystrophin Expression — But Important Biomarker Data Missing

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

World Duchenne Awareness Day 2026 (#WDAD2026)

Editorials September 5, 2026 0

Every year, World Duchenne Awareness Day (WDAD) brings the...

Beyond Micro-Dystrophin: Could Full-Length Dystrophin Be the Next Step in DMD Gene Therapy?

Research September 3, 2026 0

Renzhi Han, PhD, at Indiana University is advancing a...

NewBiologix and Synastra Partner to Advance DMD Gene Therapy Manufacturing

Press Releases September 2, 2026 0

A new international collaboration is bringing together biotechnology expertise...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.